Literature DB >> 35267141

Applying Behavioral Economics Theories to Interventions for Persons with Diabetes.

Susana R Patton1, Christopher C Cushing2, Amy Hughes Lansing3.   

Abstract

PURPOSE OF REVIEW: To introduce behavioral economics (BE), provide a description of how recent prevention and treatment interventions in persons with diabetes have incorporated BE in their intervention strategies, and discuss how BE could be used to inform new treatments for the clinical setting or research. RECENT
FINDINGS: In most of the trials described, researchers incorporated BE into their design in the form of incentives, which can align with present bias, optimism bias, and loss aversion. With only two exceptions, these trials reported preliminary support for using incentives to promote lifestyle modifications and diabetes-related tasks. Additionally, two trials reported promising results for behavior change strategies informed by default bias, while three trials reported promising results for behavior change strategies informed by social norms. Recent trials incorporating BE in prevention and treatment interventions for persons with diabetes generally report promising results, though gaps exist for research and clinical deployment.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adult; Behavioral economics; Diabetes; Lifestyle modifications; Pediatrics; Prevention; Treatment

Mesh:

Year:  2022        PMID: 35267141     DOI: 10.1007/s11892-022-01460-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  29 in total

1.  Asymmetric paternalism to improve health behaviors.

Authors:  George Loewenstein; Troyen Brennan; Kevin G Volpp
Journal:  JAMA       Date:  2007-11-28       Impact factor: 56.272

Review 2.  Acceptability of financial incentives for health-related behavior change: An updated systematic review.

Authors:  Katelin Hoskins; Connie M Ulrich; Julianna Shinnick; Alison M Buttenheim
Journal:  Prev Med       Date:  2019-07-02       Impact factor: 4.018

Review 3.  Behavioral economics as a promising framework for promoting treatment adherence to pediatric regimens.

Authors:  Jack Stevens
Journal:  J Pediatr Psychol       Date:  2014-09-12

4.  Behavioral economics.

Authors:  Colin F Camerer
Journal:  Curr Biol       Date:  2014-09-22       Impact factor: 10.834

Review 5.  The behavioral economics of health and health care.

Authors:  Thomas Rice
Journal:  Annu Rev Public Health       Date:  2013-01-07       Impact factor: 21.981

6.  State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.

Authors:  Nicole C Foster; Roy W Beck; Kellee M Miller; Mark A Clements; Michael R Rickels; Linda A DiMeglio; David M Maahs; William V Tamborlane; Richard Bergenstal; Elizabeth Smith; Beth A Olson; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2019-01-18       Impact factor: 6.118

Review 7.  Effectiveness of disease-management programs for improving diabetes care: a meta-analysis.

Authors:  Clément Pimouguet; Mélanie Le Goff; Rodolphe Thiébaut; Jean François Dartigues; Catherine Helmer
Journal:  CMAJ       Date:  2010-12-13       Impact factor: 8.262

8.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

9.  Interventions with adherence-promoting components in pediatric type 1 diabetes: meta-analysis of their impact on glycemic control.

Authors:  Korey K Hood; Jennifer M Rohan; Claire M Peterson; Dennis Drotar
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

10.  Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes.

Authors:  K Winkley; R Upsher; D Stahl; D Pollard; A Brennan; S Heller; K Ismail
Journal:  Diabet Med       Date:  2020-03-10       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.